Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Inflammatory Bowel Diseases

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Inflammatory Bowel Diseases in 1 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jung, SH1
Saxena, A1
Kaur, K1
Fletcher, E1
Ponemone, V1
Nottingham, JM1
Sheppe, JA1
Petroni, M1
Greene, J1
Graves, K1
Baliga, MS1
Fayad, R1

Other Studies

1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Inflammatory Bowel Diseases

ArticleYear
The role of adipose tissue-associated macrophages and T lymphocytes in the pathogenesis of inflammatory bowel disease.
    Cytokine, 2013, Volume: 61, Issue:2

    Topics: Adipocytes; Adipose Tissue; Adult; Arginase; Case-Control Studies; Culture Media, Conditioned; Cytok

2013